Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. twitter.com › adrenomedAdrenomed AG (@adrenomed) / Twitter

   twitter.com › adrenomed

   • Im Cache

   16. Nov. 2018 · Adrenomed AG. @adrenomed. An innovative biomarker-guided #precisionmedicine solution for patients in acute care with #sepsis and #septicshock. #enibarcimab. Hennigsdorf, Deutschland adrenomed.com Joined November 2018. 218 Following.

2. adrenomed.comAdrenomed – Adrenomed AG

   adrenomed.com

   • Im Cache

   AdrenoMed AG is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: developing precision medicine to rescue vascular integrity and saving the lives of critically ill patients with limited treatment options. The Company’s lead product candidate is Enibarcimab (INN, former name: Adrecizumab), a clinical-stage ...

3. twitter.com › adrenomed › statusAdrenomed AG on Twitter: "In #November, meet our CEO and CFO at...

   twitter.com › adrenomed › status

   13. Okt. 2022 · In #November, meet our CEO and CFO at: @LSXLeaders’ Inv€$tival #Showcase November 14, 2022, in-person in #London, UK. 13 Oct 2022 07:41:09

4. de.linkedin.com › company › adrenomed-agAdrenomed AG | LinkedIn

   de.linkedin.com › company › adrenomed-ag

   An innovative biomarker-guided precision medicine solution for patients in acute care with sepsis and septic shock | Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical...

5. adrenomed.com › category › newsNews – Adrenomed

   adrenomed.com › category › news

   • Im Cache

   13. Okt. 2022 · Hennigsdorf/Berlin (Germany), April 10, 2024 –AdrenoMed AG, the vascular integrity company, today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to its lead product candidate enibarcimab, a first-in-class non-neutralizing. 10.

6. www.dbi-ag.de › beteiligungen › adrenomedAdrecizumab - Sepsistherapie - Deutsche Biotech Innovativ AG

   www.dbi-ag.de › beteiligungen › adrenomed

   • Im Cache

   Für weitere Informationen besuchen Sie bitte www.adrenomed.com und folgen Sie Adrenomed direkt auf LinkedIn und Twitter . AdreCIZUMAB (INN: Enibarcimab) Antikörper-basierte Therapie zur Verbesserung der Gefäßintegrität

7. adrenomed.com › 20222022 – Adrenomed

   adrenomed.com › 2022

   • Im Cache

   23. Juni 2022 · Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO. Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of Adrenomed, effective today. Dr. Jones brings over 25 years of. 15.